Big insights from small samples: uncovering the potential of EUS-guided FNAs in pancreatic cancer through predictive genomics and transcriptomics.
作者信息
Zhao Melissa, Maitra Anirban, Nowak Jonathan A
机构信息
Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
出版信息
EBioMedicine. 2024 Nov;109:105380. doi: 10.1016/j.ebiom.2024.105380. Epub 2024 Oct 5.
Abstract
摘要
相似文献
1
Big insights from small samples: uncovering the potential of EUS-guided FNAs in pancreatic cancer through predictive genomics and transcriptomics.
EBioMedicine. 2024 Nov;109:105380. doi: 10.1016/j.ebiom.2024.105380. Epub 2024 Oct 5.
2
Endoscopic ultrasound-guided biopsies of pancreatic masses: comparison between fine needle aspirations and needle core biopsies.
Diagn Cytopathol. 2007 May;35(5):276-82. doi: 10.1002/dc.20621.
3
Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.
J Gastrointest Surg. 2021 Dec;25(12):3149-3159. doi: 10.1007/s11605-021-05078-y. Epub 2021 Jul 9.
4
Role of repeated endoscopic ultrasound-guided fine needle aspiration in small solid pancreatic masses with previous indeterminate and negative cytological findings.
Dig Dis. 2008;26(4):377-82. doi: 10.1159/000177025. Epub 2009 Jan 30.
5
A second endoscopic ultrasound with fine-needle aspiration for cytology identifies high-risk pancreatic cysts overlooked by current guidelines.
Diagn Cytopathol. 2021 Jan;49(1):109-118. doi: 10.1002/dc.24607. Epub 2020 Sep 22.
6
Diagnostic potency of EUS-guided FNA for the evaluation of pancreatic mass lesions.
Endosc Ultrasound. 2016 Jan-Feb;5(1):30-4. doi: 10.4103/2303-9027.175879.
7
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
Pancreas. 2011 Oct;40(7):1057-62. doi: 10.1097/MPA.0b013e3182200201.
8
Detection of B7-H4 and p53 in pancreatic cancer: potential role as a cytological diagnostic adjunct.
Pancreas. 2008 Mar;36(2):200-6. doi: 10.1097/MPA.0b013e318150e4e0.
9
Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications.
Am J Gastroenterol. 2003 Dec;98(12):2663-8. doi: 10.1111/j.1572-0241.2003.08666.x.
10
Classification of endoscopic ultrasound guided fine needle aspiration cytology of pancreatic space occupying lesions by Papanicolaou Society of Cytopathology System: A five year study.
Diagn Cytopathol. 2023 Feb;51(2):105-116. doi: 10.1002/dc.25058. Epub 2022 Sep 27.
本文引用的文献
1
Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study.
EBioMedicine. 2024 Nov;109:105373. doi: 10.1016/j.ebiom.2024.105373. Epub 2024 Oct 8.
2
Targeting KRAS in cancer.
Nat Med. 2024 Apr;30(4):969-983. doi: 10.1038/s41591-024-02903-0. Epub 2024 Apr 18.
3
Cancer statistics, 2024.
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
4
KRAS Mutation Testing on Endoscopic Ultrasound-Guided Fine-Needle Aspiration Samples Improves the Diagnostic Accuracy of Pancreatic Cancer.
Pancreas. 2022;51(10):1365-1371. doi: 10.1097/MPA.0000000000002193.
5
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma.
Cancers (Basel). 2022 Dec 16;14(24):6223. doi: 10.3390/cancers14246223.
6
The current state of the art and future trends in RAS-targeted cancer therapies.
Nat Rev Clin Oncol. 2022 Oct;19(10):637-655. doi: 10.1038/s41571-022-00671-9. Epub 2022 Aug 26.
7
Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
Cancer Cytopathol. 2022 Apr;130(4):275-283. doi: 10.1002/cncy.22533. Epub 2021 Dec 14.
8
Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer.
Clin Cancer Res. 2020 Jan 1;26(1):82-92. doi: 10.1158/1078-0432.CCR-19-1467. Epub 2019 Nov 21.
9
Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer.
World J Gastroenterol. 2014 Aug 21;20(31):10758-68. doi: 10.3748/wjg.v20.i31.10758.
10
Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration.
Gastroenterol Res Pract. 2012;2012:243524. doi: 10.1155/2012/243524. Epub 2012 Nov 8.
Zotero 插件